Search Results - "PARAMESWARAN, Reshmi"
-
1
A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers
Published in Nature communications (11-01-2022)“…B cell-activating factor (BAFF) binds the three receptors BAFF-R, BCMA, and TACI, predominantly expressed on mature B cells. Almost all B cell cancers are…”
Get full text
Journal Article -
2
Repression of GSK3 restores NK cell cytotoxicity in AML patients
Published in Nature communications (04-04-2016)“…Natural killer cells from acute myeloid leukaemia patients (AML-NK) show a dramatic impairment in cytotoxic activity. The exact reasons for this dysfunction…”
Get full text
Journal Article -
3
Inhibition of O-GlcNAcylation Decreases the Cytotoxic Function of Natural Killer Cells
Published in Frontiers in immunology (11-04-2022)“…Natural killer (NK) cells mediate killing of malignant and virus-infected cells, a property that is explored as a cell therapy approach in the clinic. Various…”
Get full text
Journal Article -
4
Wheat Germ Agglutinin as a Potential Therapeutic Agent for Leukemia
Published in Frontiers in oncology (21-02-2019)“…Dietary lectins are carbohydrate-binding proteins found in food sources. We used a panel of seven dietary lectins to analyze cytotoxicity against hematological…”
Get full text
Journal Article -
5
NF-κB c-Rel Is Dispensable for the Development but Is Required for the Cytotoxic Function of NK Cells
Published in Frontiers in immunology (29-04-2021)“…Natural Killer (NK) cells are cytotoxic lymphocytes critical to the innate immune system. We found that germline deficiency of NF-κB c-Rel results in a marked…”
Get full text
Journal Article -
6
Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy
Published in Blood (07-03-2013)“…Bone marrow (BM) provides chemoprotection for acute lymphoblastic leukemia (ALL) cells, contributing to lack of efficacy of current therapies. Integrin alpha4…”
Get full text
Journal Article -
7
BAFF receptor antibody for mantle cell lymphoma therapy
Published in Oncoimmunology (01-01-2021)“…Mantle cell lymphoma (MCL) is an aggressive form of B cell non-Hodgkin's lymphoma and remains incurable under current treatment modalities. One of the main…”
Get full text
Journal Article -
8
A Functional Receptor for B-Cell-Activating Factor Is Expressed on Human Acute Lymphoblastic Leukemias
Published in Cancer research (Chicago, Ill.) (01-06-2010)“…B-lineage acute lymphoblastic leukemia (ALL) arises by transformation of a progenitor (pre-B) cell. Cure rates in adults remain low and treatment is…”
Get full text
Journal Article -
9
O-acetylated N-acetylneuraminic acid as a novel target for therapy in human pre-B acute lymphoblastic leukemia
Published in The Journal of experimental medicine (08-04-2013)“…The development of resistance to chemotherapy is a major cause of relapse in acute lymphoblastic leukemia (ALL). Though several mechanisms associated with drug…”
Get full text
Journal Article -
10
The role of Cdk5/p35 kinase activity in natural killer cell cytotoxicity
Published in The Journal of immunology (1950) (01-05-2022)“…Abstract Natural killer (NK) cells and T cells are immune cells with cytotoxic function, but while the distinct role of Cyclin-dependent kinase 5 (Cdk5) in the…”
Get full text
Journal Article -
11
Hexosamine Biosynthetic Pathway Inhibition Leads to AML Cell Differentiation and Cell Death
Published in Molecular cancer therapeutics (01-10-2018)“…Treatment for acute myeloid leukemia (AML) has remained unchanged for past 40 years. Targeting cell metabolism is a promising avenue for future cancer therapy…”
Get full text
Journal Article -
12
Activin β A in term placenta and its correlation with placental inflammation in parturients having epidural or systemic meperidine analgesia: a randomized study
Published in Journal of clinical anesthesia (01-05-2007)“…Abstract Study Objective To investigate the immunohistochemical localization of β A subunit of activin A in human term placenta, as a marker for placental…”
Get full text
Journal Article -
13
The Mesenchymal Stroma Negatively Regulates B Cell Lymphopoiesis through the Expression of Activin A
Published in Annals of the New York Academy of Sciences (01-05-2003)“…: The negative control of B cell generation is only partially resolved. We assessed the role of activin A in regulation of B lymphopoiesis in view of its…”
Get full text
Journal Article -
14
Ligand Based CAR T-Cell Targeting BAFF Receptors Asa Novel Therapy for B Cell Malignancies
Published in Blood (05-11-2020)“…Background: Autologous T cells engineered to express chimeric antigen receptors (CARs) targeting CD19 have shown rapid and durable responses in B cell…”
Get full text
Journal Article -
15
The mesenchyme expresses T cell receptor mRNAs: relevance to cell growth control
Published in Oncogene (21-03-2002)“…The mesenchyme plays a crucial regulatory role in organ formation and maintenance. However, comprehensive molecular characterization of these cells is lacking…”
Get full text
Journal Article -
16
A new Natural Killer cell therapy to target relapse Acute Lymphoblastic Leukemia
Published in The Journal of immunology (1950) (01-05-2020)“…Abstract Acute Lymphoblastic Leukemia (ALL) is the most common childhood cancer. Drug resistance and relapse are two major problems in ALL. Pre-B ALL cells…”
Get full text
Journal Article -
17
Abstract 2696: PPAR beta/delta is a novel therapeutic target in acute myeloid leukemia
Published in Cancer research (Chicago, Ill.) (01-10-2014)“…Abstract Acute myeloid leukemia (AML) is characterized by the differentiation arrest and rapid proliferation of abnormal white blood cells. Current…”
Get full text
Journal Article -
18
Deficiency of Nuclear Factor-κB c-Rel Accelerates the Development of Autoimmune Diabetes in NOD Mice
Published in Diabetes (New York, N.Y.) (01-08-2016)“…The nuclear factor-κB protein c-Rel plays a critical role in controlling autoimmunity. c-Rel-deficient mice are resistant to streptozotocin-induced diabetes, a…”
Get full text
Journal Article -
19
Abstract 3186: A novel combination therapy for treating advanced drug resistant acute lymphoblastic leukemia
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract Purpose: Drug resistance and relapse are two major problems in Acute Lymphoblastic Leukemia (ALL) as these patients do not respond to chemotherapy. We…”
Get full text
Journal Article -
20
Deficiency of Nuclear Factor-[kappa]B c-Rel Accelerates the Development of Autoimmune Diabetes in NOD Mice
Published in Diabetes (New York, N.Y.) (01-08-2016)“…The nuclear factor-...B protein c-Rel plays a critical role in controlling autoimmunity. c-Rel-deficient mice are resistant to streptozotocin-induced diabetes,…”
Get full text
Journal Article